ECMO blood thinner showdown: which drug wins?
NCT ID NCT05959252
First seen May 09, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study tests two blood thinners, bivalirudin and heparin, in 80 adults on ECMO (a machine that helps the heart and lungs). The goal is to see which drug keeps blood thin enough to prevent clots without causing dangerous bleeding. Participants are randomly assigned to one of the two drugs. The study also looks at costs and how often the ECMO circuit needs to be changed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Royal Prince Alfred Hospital
RECRUITINGSydney, New South Wales, 2050, Australia
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.